Prosecution Insights
Last updated: November 04, 2026

Plant Sciences Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days

Analysis

Plant Sciences Inc. is managing 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This prosecution is localized to 1 distinct examiner and 1 distinct art unit. The narrow scope of current activity suggests a focused interaction with the patent office, where a single technical matter is being evaluated by a single individual. The presence of the 1 distinct art unit confirms that the company's current legal focus is confined to a specific technical niche within the broader field.

WILLIAMS, KEITH RICHARD is the busiest examiner for this company, handling the pending office action. Because there is only 1 distinct examiner in total, this individual accounts for the company's current pending workload. The relationship between the 1 distinct examiner and the technical group indicates a streamlined prosecution path for the company's current Biotechnology & Pharmaceuticals filings, with no additional pending actions distributed elsewhere in the patent office.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WILLIAMS, KEITH RICHARD 1 44.4% +0.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18792335 FUSARIUM WILT RESISTANCE GENES WILLIAMS, KEITH RICHARD —

Top Art Units

Art UnitApps
1663 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18792335 FUSARIUM WILT RESISTANCE GENES WILLIAMS, KEITH RICHARD 1663 §103§112 Non-Final OA — Pending Aug 01, 2024

Managing Plant Sciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Plant Sciences Inc. have?

Plant Sciences Inc. has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Plant Sciences Inc. applications?

Keith Richard Williams has the most, with 1 of Plant Sciences Inc.'s pending office actions.

What technology area are Plant Sciences Inc.'s patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month